Prescription drug · ANDA
brivaracetam NDC 72205-268
Brivaracetam 25 mg/1 · Tablet, Film coated · Oral · Novadoz Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72205-268-06 | 72205026806 | 100 BLISTER PACK in 1 CARTON (72205-268-06) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Feb 1, 2026 | |
| 72205-268-60 | 72205026860 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-268-60)Marketed from Feb 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 25 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Novadoz Pharmaceuticals LLCNDC labeler code 72205
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214921
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 72205-268_e87caa94-1064-4a45-91e8-0219eb1d2d39SPL ID e87caa94-1064-4a45-91e8-0219eb1d2d39SPL set ID 11ca0e1d-1c0d-4357-9ebd-ee1e87185ddeRxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0372205270602, 0372205267602, 0372205271609, 0372205268609, 0372205269606, 0372205268067, 0372205271012, 0372205268012, 0372205269019, 0372205271067
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472205026806followed by a unit qualifier and the quantityPackage 72205-0268-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 72205-268
- What is NDC 72205-268?
- 72205-268 is the product NDC for brivaracetam, Brivaracetam 25 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- brivaracetam.
- What is the active ingredient?
- Brivaracetam.
- Who is the labeler?
- Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for brivaracetam?
- 52 other product NDCs are listed under this name. See all brivaracetam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other brivaracetam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brivaracetam | Brivaracetam 10 mg/mL | SolutionOral | Aurobindo Pharma Limited | 59651-995 | 59651-0995-03 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-823 | 76282-0823-60 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-822 | 76282-0822-60 |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-824 | 76282-0824-60 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-825 | 76282-0825-60 |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-826 | 76282-0826-60 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-068 | 84386-0068-60 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-069 | 84386-0069-60 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-071 | 84386-0071-60 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-074 | 73190-0074-60 |
Other NDCs under ANDA 214921
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-075 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-074 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-076 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-077 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-267 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-271 |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-269 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-270 |